Detalhe da pesquisa
1.
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors.
J Hepatol
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428641
2.
Long-term outcomes (beyond 5 years) of liver transplant recipients-A transatlantic multicenter study.
Liver Transpl
; 30(2): 170-181, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589505
3.
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis.
Liver Int
; 44(2): 279-285, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100141
4.
What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations.
Clin Transplant
; 36(10): e14631, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35257411
5.
Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study.
Infection
; 50(2): 371-380, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331263
6.
Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy.
Ann Hepatol
; 27(3): 100687, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192963
7.
Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus.
Am J Transplant
; 21(9): 3148-3156, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33749113
8.
A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.
J Hepatol
; 75(2): 275-283, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33746085
9.
Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort.
Transpl Int
; 34(10): 1908-1913, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121244
10.
Outcomes of antiviral treatment in hepatitis C virus liver transplant patients off immunosuppression in the direct acting antivirals era: A case series.
Clin Transplant
; 32(7): e13303, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29851150
11.
Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
Transpl Infect Dis
; 20(1)2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29125670
12.
Transplantation, HIV Serostatus, and Registry Data: Room for Improvement.
Am J Transplant
; 22(9): 2283-2284, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429220
13.
Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients.
Am J Transplant
; 22(2): 673-675, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34554648
14.
Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study.
Liver Transpl
; 28(7): 1257-1261, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255179
15.
Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant.
Ann Hepatol
; 16(1): 86-93, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28051797
16.
Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus.
Clin Transplant
; 30(9): 1140-5, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27411037
17.
Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.
Clin Infect Dis
; 60(1): 108-16, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25228702
18.
Doubtful Role of IL28B Polymorphism in Occult Hepatitis B Infection.
Intervirology
; 58(3): 160-5, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26022419
19.
Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study.
Liver Transpl
; 20(7): 856-63, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24723503
20.
Outcome of early vs. deferred antiviral treatment for recurrent hepatitis C in liver transplant recipients.
Ann Hepatol
; 13(2): 219-30, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552864